Physio-Assist
8
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.5%
1 terminated/withdrawn out of 8 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis
Role: lead
Intermittent Intrapulmonary Deflation and Dyspnea Following Exercise in People With Chronic Obstructive Pulmonary Disease
Role: collaborator
Efficacy of Simeox Airway Clearance Therapy in Children With Cystic Fibrosis
Role: lead
Home Airway Clearance in CF Patients
Role: lead
Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH
Role: lead
Home Airway Clearance in Patients With Bronchiectasis (Home-Care Bronchiectasis)
Role: lead
Ancillary Home Airway Clearance in CF Patients ( HomeCareSIMEOX )
Role: lead
Evaluation of the Safety of the Medical Device Simeox®
Role: lead
All 8 trials loaded